Senior insider sale
President and CEO at OLEMA PHARMACEUTICALS, INC. — senior position signals high conviction
$490.2K
52.33K shares
What this filing means
BOHEN SEAN plans to sell 52.33K shares of OLEMA PHARMACEUTICALS, INC. valued at approximately $490.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/10/2024ACC: 0001959173-24-008552
DirectorOfficer· President and CEO
Since Nov 2020
52.33K
Shares to sell
$490.2K
Approx. market value
52.33K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
12/9/2024
52.33KTotal acquired52.33K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/9/2024 | Restricted Stock Vesting Compensation | 52.33K | — |
| Total | 52.33K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
52.33K
Market value
$490.2K
12/10/2024
Total
Units
52.33K
Value
$490.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/10/2024 | 52.33K | $490.2K | NASDAQ | Planned |
| Total | 52.33K | $490.2K | ||